Breaking
Friday, June 19, 2026

Biopharma

🇺🇸 FDA Page 2

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Global biopharma insights for investors & BD. Track drug development, M&A, and market trends shaping the pharmaceutical landscape.

Showing 13–24 of 69 articles

High impact AnalysisJun 4, 2026

Mercury Acquires King Courier to Grow Bay Area Logistics: Deal Intelligence for Pharma Teams

5 min

Dr. Sarah Mitchell
High impact AnalysisJun 4, 2026

Best Biotech News Sources: How Legend Biotech Emerged as a Rare Market Winner

6 min

Dr. Sarah Mitchell
High impact NewsJun 4, 2026

Fierce Biotech Week 2026: Key Insights and Highlights

FDA · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

House bill aims to crack down on China biotech deals

5 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

ASCO Summit: Ivonescimab's China Lung Data Shows Promise, But Global Validation Remains Key

lung · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

CG Life Appoints Collette Douaihy Chief Creative Officer to Drive Biopharma Marketing Innovation

FDA · 9 min

Dr. Sarah Mitchell
High impact NewsJun 3, 2026

Vir Biotechnology Stock: Board Reshuffle and Governance Votes Post-AGM

FDA · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

STAT+ R&D Performance Ranking: Insights for Pharma Companies

FDA · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

TrumpRx's Generic Drug Expansion: Strategic Implications for the Pharmaceutical Industry

FDA · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

Eli Lilly and Ascidian Therapeutics Forge RNA Exon Editing Alliance for Genetic Kidney Diseases

genetic kidney diseases · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

Opinion: How the military may be fueling eating disorders in men

eating disorders · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Sun Pharma and Organon File HSR, Awaiting Antitrust Clearance

7 min

Dr. Sarah Mitchell